Welcome to Inform Genomics, Inc.
Inform Genomics, Inc. is a private company focused on developing novel platforms of genomic-based personalized medicine products for cancer supportive care.
The company’s business model leverages existing technology in conjunction with proprietary analytic methods to identify interactions of genes and single nucleotide polymorphisms (SNPs) that predict individual patient’s risk for developing common side effects from chemotherapy regimens.
When commercially available, our products are expected to provide actionable information for providers, patients, and payers that will customize cancer care and improve outcomes.
The US market opportunity for these differentiated products exceeds $1 billion annually. Inform Genomics is headquartered in Boston, Massachusetts.